Cardiovascular disease in end-stage renal disease

Jung Tak Park, Hyung Jung Oh, Shin Wook Kang

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The number of end-stage renal disease (ESRD) patients is progressively growing with more than 60,000 ESRD patients on renal replacement therapy in Korea. The mortality risk in ESRD patients is approximately 10 to 20-fold higher compared to the general population, which is mainly attributed to prevalent cardiovascular disease in these patients. However, the risk factors for cardiovascular disease in ESRD patients are different from the general population, and useful biomarkers for predicting cardiovascular mortality are not completely defined. The nationwide multicenter Clinical Research Center (CRC) for ESRD program was initiated in Korea not only to elucidate the incidence and prevalence of cardiovascular disease in ESRD patients but also to identify potential risk factors including various biomarkers for cardiovascular disease. A prospective cohort of 864 incident hemodialysis patients, from 34 dialysis centers of the CRC for ESRD in Korea, was followed up for 36 months, and the clinical outcome of these patients was reviewed. This article presents the recent data from the CRC for ESRD program, and, in addition, brief reviews on key risk factors and potential biomarkers for cardiovascular disease in ESRD patients.

Original languageEnglish
Pages (from-to)576-582
Number of pages7
JournalJournal of the Korean Medical Association
Volume56
Issue number7
DOIs
Publication statusPublished - 2013 Jul 1

Fingerprint

Chronic Kidney Failure
Cardiovascular Diseases
Korea
Biomarkers
Research
Renal Replacement Therapy
Mortality
Population
Renal Dialysis
Dialysis
Incidence

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Park, Jung Tak ; Oh, Hyung Jung ; Kang, Shin Wook. / Cardiovascular disease in end-stage renal disease. In: Journal of the Korean Medical Association. 2013 ; Vol. 56, No. 7. pp. 576-582.
@article{bcaaedf07e9b4888b84b3cdf5079e26f,
title = "Cardiovascular disease in end-stage renal disease",
abstract = "The number of end-stage renal disease (ESRD) patients is progressively growing with more than 60,000 ESRD patients on renal replacement therapy in Korea. The mortality risk in ESRD patients is approximately 10 to 20-fold higher compared to the general population, which is mainly attributed to prevalent cardiovascular disease in these patients. However, the risk factors for cardiovascular disease in ESRD patients are different from the general population, and useful biomarkers for predicting cardiovascular mortality are not completely defined. The nationwide multicenter Clinical Research Center (CRC) for ESRD program was initiated in Korea not only to elucidate the incidence and prevalence of cardiovascular disease in ESRD patients but also to identify potential risk factors including various biomarkers for cardiovascular disease. A prospective cohort of 864 incident hemodialysis patients, from 34 dialysis centers of the CRC for ESRD in Korea, was followed up for 36 months, and the clinical outcome of these patients was reviewed. This article presents the recent data from the CRC for ESRD program, and, in addition, brief reviews on key risk factors and potential biomarkers for cardiovascular disease in ESRD patients.",
author = "Park, {Jung Tak} and Oh, {Hyung Jung} and Kang, {Shin Wook}",
year = "2013",
month = "7",
day = "1",
doi = "10.5124/jkma.2013.56.7.576",
language = "English",
volume = "56",
pages = "576--582",
journal = "Journal of the Korean Medical Association",
issn = "1975-8456",
publisher = "Korean Medical Association",
number = "7",

}

Cardiovascular disease in end-stage renal disease. / Park, Jung Tak; Oh, Hyung Jung; Kang, Shin Wook.

In: Journal of the Korean Medical Association, Vol. 56, No. 7, 01.07.2013, p. 576-582.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Cardiovascular disease in end-stage renal disease

AU - Park, Jung Tak

AU - Oh, Hyung Jung

AU - Kang, Shin Wook

PY - 2013/7/1

Y1 - 2013/7/1

N2 - The number of end-stage renal disease (ESRD) patients is progressively growing with more than 60,000 ESRD patients on renal replacement therapy in Korea. The mortality risk in ESRD patients is approximately 10 to 20-fold higher compared to the general population, which is mainly attributed to prevalent cardiovascular disease in these patients. However, the risk factors for cardiovascular disease in ESRD patients are different from the general population, and useful biomarkers for predicting cardiovascular mortality are not completely defined. The nationwide multicenter Clinical Research Center (CRC) for ESRD program was initiated in Korea not only to elucidate the incidence and prevalence of cardiovascular disease in ESRD patients but also to identify potential risk factors including various biomarkers for cardiovascular disease. A prospective cohort of 864 incident hemodialysis patients, from 34 dialysis centers of the CRC for ESRD in Korea, was followed up for 36 months, and the clinical outcome of these patients was reviewed. This article presents the recent data from the CRC for ESRD program, and, in addition, brief reviews on key risk factors and potential biomarkers for cardiovascular disease in ESRD patients.

AB - The number of end-stage renal disease (ESRD) patients is progressively growing with more than 60,000 ESRD patients on renal replacement therapy in Korea. The mortality risk in ESRD patients is approximately 10 to 20-fold higher compared to the general population, which is mainly attributed to prevalent cardiovascular disease in these patients. However, the risk factors for cardiovascular disease in ESRD patients are different from the general population, and useful biomarkers for predicting cardiovascular mortality are not completely defined. The nationwide multicenter Clinical Research Center (CRC) for ESRD program was initiated in Korea not only to elucidate the incidence and prevalence of cardiovascular disease in ESRD patients but also to identify potential risk factors including various biomarkers for cardiovascular disease. A prospective cohort of 864 incident hemodialysis patients, from 34 dialysis centers of the CRC for ESRD in Korea, was followed up for 36 months, and the clinical outcome of these patients was reviewed. This article presents the recent data from the CRC for ESRD program, and, in addition, brief reviews on key risk factors and potential biomarkers for cardiovascular disease in ESRD patients.

UR - http://www.scopus.com/inward/record.url?scp=84881109856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881109856&partnerID=8YFLogxK

U2 - 10.5124/jkma.2013.56.7.576

DO - 10.5124/jkma.2013.56.7.576

M3 - Review article

AN - SCOPUS:84881109856

VL - 56

SP - 576

EP - 582

JO - Journal of the Korean Medical Association

JF - Journal of the Korean Medical Association

SN - 1975-8456

IS - 7

ER -